Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aurel Prosz

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Scientific Reports|November 23, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
NPJ Precision Oncology|May 6, 2024
Author Correction: Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targetingAurel Prosz, Pranshu Sahgal, Brandon M Huffman, et al.
NPJ Precision Oncology|April 8, 2024
Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targetingAurel Prosz, Pranshu Sahgal, Brandon M Huffman, et al.
Cell Reports|February 14, 2026
Generation of a comprehensive epigenomic atlas in clear cell renal cell carcinoma informs kidney cancer progression and heritabilitySarah Abou Alaiwi, Elio Adib, Ziwei Zhang, et al.
NPJ Precision Oncology|September 18, 2024
Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progressionMiklos Diossy, Viktoria Tisza, Hua Li, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Scientific Reports|November 23, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
NPJ Precision Oncology|May 6, 2024
Author Correction: Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targetingAurel Prosz, Pranshu Sahgal, Brandon M Huffman, et al.
NPJ Precision Oncology|April 8, 2024
Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targetingAurel Prosz, Pranshu Sahgal, Brandon M Huffman, et al.
Cell Reports|February 14, 2026
Generation of a comprehensive epigenomic atlas in clear cell renal cell carcinoma informs kidney cancer progression and heritabilitySarah Abou Alaiwi, Elio Adib, Ziwei Zhang, et al.
NPJ Precision Oncology|September 18, 2024
Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progressionMiklos Diossy, Viktoria Tisza, Hua Li, et al.
Pageof 2